Cyclooxygenase 2 expression in soft tissue leiomyosarcoma

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 2913-2917

  Herceg, Megan E ^a   Tsiatis, Athanasios C ^b   Halpern, Jennifer L ^a   Holt, Ginger E ^a   Schwartz, Herbert S ^a   Keedy, Vicki L ^c   Cates, Justin M M ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

COX2; Immunohistochemistry; Leiomyosarcoma; Tumor necrosis

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DRUG TARGETING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; METASTASIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; TUMOR NECROSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LEIOMYOSARCOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SARCOMA; YOUNG ADULT;

EID: 68549128630     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gustafson P: Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl 259: 1-31, 1994.
2. Gustafson P, Willen H, Baldetorp B, Ferno M, Akerman M and Rydholm A: Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer 70: 114-119, 1992.
3. Hashimoto H, Daimaru Y, Tsuneyoshi M and Enjoji M: Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study. Cancer 57: 2077-2088, 1986.
4. Massi D, Beltrami G, Mela MM, Pertici M, Capanna R and Franchi A: Prognostic factors in soft tissue leiomyosarcoma of the extremities: A retrospective analysis of 42 cases. Eur J Surg Oncol 30: 565-572, 2004. (Pubitemid 38701882)
5. Svarvar C, Bohling T, Berlin O, Gustafson P, Folleras G, Bjerkehagen B, Domanski HA, Sundby Hall K, Tukiainen E and Blomqvist C: Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group. Cancer 109: 282-291, 2007. (Pubitemid 46106243)
6. Thomas B, Berenbaum F, Humbert L, Bian H, Bereziat G, Crofford L and Olivier JL: Critical role of C/EBPδ and C/EBPβ factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1β in articular chondrocytes. Eur J Biochem 267: 6798-6809, 2000. (Pubitemid 30944835)
7. Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB and Subbaramaiah K: Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2: 544-551, 2001. (Pubitemid 33586867)
8. Turini ME and DuBois RN: Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53: 35-57, 2002.
9. Williams CS, Mann M and DuBois RN: The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18: 7908-7916, 1999. (Pubitemid 30066236)
10. Dickens DS, Kozielski R, Khan J, Forus A and Cripe TP: Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol 5: 356-364, 2002.
11. Dickens DS, Kozielski R, Leavey PJ, Timmons C and Cripe TP: Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma. J Pediatr Hematol Oncol 25: 282-285, 2003. (Pubitemid 36506213)
12. Lassus P, Ristimaki A, Huuhtanen R, Tukiainen E, Asko-Seljavaara S, Andersson LC, Miettinen M, Blomqvist C, Haglund C and Bohling T: Cyclooxygenase-2 expression in human soft-tissue sarcomas is related to epithelial differentiation. Anticancer Res 25: 2669-2674, 2005. (Pubitemid 41044645)
13. Raspollini MR, Amunni G, Villanucci A, Paglierani M and Taddei GL: Cyclooxygenase-2 expression in uterine leiomyosarcomas. J Chemother 16: 577-581, 2004.
14. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG and Morrow M: AJCC Cancer Staging Manual. New York, Springer-Verlag., pp. 193-200, 2002.
15. Fletcher CDM, Rydholm A, Sinder S, Sundaram M and Coindre JM: In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Fletcher CDM, Unni KK and Mertens F (eds.). Lyon, IARC Press, pp. 12-18, 2002.
16. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK and McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85: 200-206, 1993. (Pubitemid 23046895)
17. Kirkman TW: Statistics to use. http://www.physics.csbsju.edu/stats (accessed 23 Feb 2009).
18. Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H and Dubinett SM: Non-small cell lung cancer cyclooxygenase-2- dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 58: 1208-1216, 1998. (Pubitemid 28183210)
19. Ohno R, Yoshinaga K, Fujita T, Hasegawa K, Iseki H, Tsunozaki H, Ichikawa W, Nihei Z and Sugihara K: Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 91: 1876-1881, 2001.
20. Tsujii M, Kawano S and DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340, 1997. (Pubitemid 27157312)
21. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT and Fahey TJ: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59: 987-990, 1999. (Pubitemid 29135954)
22. Madaan S, Abel PD, Chaudhary KS, Hewitt R, Stott MA, Stamp GW and Lalani EN: Cytoplasmic induction and overexpression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment. BJU Int 86: 736-741, 2000. (Pubitemid 30775487)
23. Stewart AE, Heslin MH, Arch J, Jhala N, Ragland B, Gomez F, Bland KI and Arnoletti JP: Cyclooxygenase-2 expression and clinical outcome in gastrointestinal stromal tumors. J Gastrointest Surg 10: 315-319, 2006. (Pubitemid 43187198)
24. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H and Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58: 4997-5001, 1998. (Pubitemid 28521147)
25. Deininger MH, Weller M, Streffer J, Mittelbronn M and Meyermann R: Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol 98: 240-244, 1999. (Pubitemid 29396854)
26. Shono T, Tofilon PJ, Bruner JM, Owolabi O and Lang FF: Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61: 4375-4381, 2001. (Pubitemid 32685762)
27. Sminia P, Stoter TR, van der Valk P, Elkhuizen PH, Tadema TM, Kuipers GK, Vandertop WP, Lafleur MV and Slotman BJ: Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme. J Cancer Res Clin Oncol 131: 653-661, 2005. (Pubitemid 41502208)
28. Royds JA, Dower SK, Qwarnstrom EE and Lewis CE: Response of tumour cells to hypoxia: role of p53 and NF-κB. Mol Pathol 51: 55-61, 1998.
29. Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN and Runge MS: Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272: 601-608, 1997.